Imc Chicago, LLC Bio N Tech Se Transaction History
Imc Chicago, LLC
- $3.34 Billion
- Q4 2024
A detailed history of Imc Chicago, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Imc Chicago, LLC holds 13,304 shares of BNTX stock, worth $1.45 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,304
Previous 32,436
58.98%
Holding current value
$1.45 Million
Previous $3.85 Million
60.67%
% of portfolio
0.05%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$894 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$479 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$467 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$206 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$197 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...